Updated time: 2022-12-28 09:46:43
14A-950305
TW I733026、US 11,517,600 B2
Using a novel in vivo and in vitro “bioactivity-guided fractionation strategy and protocol”, we found an active fraction and pure compounds from C. rabens as potential cancer chemopreventive agents. At the meantime, we have established chemical fingerprinting of the active subfraction of C. rabens using HPLC-APCI/MS for the purpose of QA/QC the consistency and efficacy of the extract. Based on these results, the C. rabens extract and their phytochemical derivatives are potential chemopreventive remedies or nutraceuticals for human disorders, e.g., cancer or inflammation.
In this invention, we have established the methods and procedures for preparation of bioactive C. rabens extracts. This is also the first to identify and define the new usage of the derived fractions and phytochemical compounds of C. rabens extract as remedies or nutraceuticals for chemoprevention. The chemical fingerprinting and index compounds of the active fraction of C. rabens have established for the purpose of QA/QC the consistency and efficacy of the plant extract for further development as healthy food or botanical drugs.
- For chemoprevention or complementary/alternative control of the situations of various human disorders, e.g., malignant disease or inflammation.
- The bioactive extract and compound group discovered in the invention can be further developed as healthy food or botanical drugs.
Lie-Fen Shyur、Chia-Chung Hou、Jyh-Horng Wu、Yi-Ping Chen、Sheng-Yang Wang、Chi-Chang Huang、Ning-Sun Yan
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

An active fraction or pure compounds of the Crassocephalum rabens as potential cancer chemopreventive agents.